Sir,

Recent reports highlight the possible genetic background of chronic spontaneous urticaria (CSU). According to eligible published papers, polymorphisms in genes related to inflammation and autoimmunity may predispose to CSU.\[[@ref1][@ref2]\] Tumor necrosis factor (TNF) is secreted mainly by macrophages and mast cells and acts as a multifunctional pro-inflammatory cytokine. Its synthesis is augmented on mast cell activation. A few controlled studies showed that TNF-α is upregulated in patients with CSU.\[[@ref3]\] Moreover, a few trials in small series gave promising results with TNF-α inhibitors as an effective tool in controlling recalcitrant CSU. Since the role of TNF-α in CSU is suspected, the role of certain polymorphisms of TNF-α can be hypothesized.

In our study, patients' group was composed of 153 unrelated CSU patients (91 females and 62 males, mean age: 36.4 years, range: 19--61) with positive autologous serum skin test (ASST) result. The control group was composed of 106 unrelated healthy volunteers (70 females and 36 males, mean age: 38.9 years, range: 18--59). All individuals were Caucasian and came from the Polish population. Disease severity was analyzed by a 7-day assessment with the Urticaria Activity Score. The age of disease onset was also analyzed. In all the examined subjects, we studied *TNF1*α rs1799964, rs1799724, and rs1800629 polymorphisms. In statistical analyses, we used Chi-square, odds ratio, and ANOVA tests. The study was approved by the Bioethics Committee of the Medical University of Silesia in Katowice, Poland.

Hardy--Weinberg equilibrium assay revealed no deviation in the examined groups. The allele or genotype distribution analysis resulted in no statistically significant differences between CSU patients and controls \[[Table 1](#T1){ref-type="table"}\]. There were no differences in haplotype frequencies \[[Table 2](#T2){ref-type="table"}\]. In addition, no relation was proved between *TNF1*α polymorphisms and urticaria severity or the age of disease onset.

###### 

Tumor necrosis factor 1-α genotypes and allele distribution in chronic spontaneous urticaria patients and healthy controls

  SNP         Group        Genotype distribution Total number (%)   Allele Total number (%)   OR (95% CI)   *P*                                         
  ----------- ------------ ---------------------------------------- ------------------------- ------------- ------------ ----------- ------------------ ------
  rs1799964   CSU          TT 103 (67)                              TC 46 (30)                CC 4 (3)      T 252 (82)   C 54 (18)   1.05 (0.60-1.85)   0.89
  Controls    TT 70 (66)   TC 31 (29)                               CC 5 (5)                  T 171 (81)    C 41 (19)    *P*'=0.64                      
  rs1799724   CSU          CC 115 (75)                              CT 35 (23)                TT 3 (2)      C 265 (87)   T 41 (13)   1.37 (0.76-2.46)   0.32
  Controls    CC 73 (69)   CT 31 (29)                               TT 2 (2)                  C 177 (83)    T 35 (17)    *P*'=0.38                      
  rs1800629   CSU          GG 103 (67)                              GA 48 (31)                AA 2 (1)      G 254 (83)   A 52 (17)   1.06 (0.60-1.85)   0.89
  Controls    GG 70 (66)   GA 35 (33)                               AA 1 (1)                  G 175 (83)    A 37 (17)    *P*'=0.91                      

The OR was calculated for patients homozygous or heterozygous carrying risk allele versus homozygous. OR: Odds ratio, CI: Confidence interval, *P*: Statistical significance, *P*': Allele frequency statistical significance, CSU: Chronic spontaneous urticaria, SNP: Single nucleotide polymorphism

###### 

Tumor necrosis factor 1-alpha haplotype distribution in chronic spontaneous urticaria patients and healthy controls

  Haplotypes rs1799964/rs1799724/rs1800629   CSU (*n*=306 haplotypes) frequency (95% CI)   Control group (*n*=212 haplotypes) frequency (95% CI)   *P*
  ------------------------------------------ --------------------------------------------- ------------------------------------------------------- -----
  TTG                                        10.5 (6.8-14.9)                               15.1 (10.1-20.5)                                        NS
  CCA                                        0.5 (0.1-1.8)                                 2.3 (0.6-5.1)                                           NS
  TCG                                        55.4 (49.5-61.3)                              50.8 (43.3-57.9)                                        NS
  CTA                                        0                                             0.4 (0.1-1.7)                                           \-
  TTA                                        2.4 (0.1-4.9)                                 0.0 (0)                                                 \-
  CCG                                        16.6 (12.7-21.1)                              15.6 (10.7-21.1)                                        NS
  TCA                                        14.0 (9.5-18.8)                               14.4 (9.4-19.4)                                         NS
  CTG                                        0.5 (0-2.1)                                   1.3 (0.1-3.9)                                           NS

*P*: Statistical significance, CI: Confidence interval, CSU: Chronic spontaneous urticaria, NS: Not significant

The contribution of autoimmunity to the pathogenesis of CSU is obvious; however, the exact mechanisms involved are still open to debate. Therefore, patients with positive ASST were enrolled in our study. One of the genes considered in CSU pathogenesis is *TNF*-α gene. Choi *et al*.\[[@ref4]\] demonstrated that *TNF*-α polymorphisms at --1031T/C and --863C/A as well as their haplotypes were significantly associated with aspirin-induced urticaria in the Korean population. Tavakol *et al*.\[[@ref5]\] showed in the Iranian population that G allele was significantly higher in CSU patients at locus --238G/A and --308G/A of *TNF*-α gene and concluded that this polymorphism can affect susceptibility to this disorder. Our data did not confirm the observation of a potent link between *TNF*-α polymorphisms at --1031 T/C, --857C/T, and --308G/A and CSU in the Polish population. To the best of our knowledge, this is the first study considering the role of the above-mentioned polymorphisms in the pathogenesis of CSU. Further analyses should be conducted on large population stratified by ethnicity. Genetics seem to be a promising direction in further search for CSU pathogenesis.
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